{
  "docId": "019de073-dba4-758b-bcbe-08ad83e87d71",
  "docSlug": "afc13b14322819221680611098a4aee7",
  "documentTitle": "Third Harmonic Bio | Investor Presentation Deck | 20 slides",
  "authorId": "third-harmonic-bio",
  "authorName": "Third Harmonic Bio",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 3,
  "pageCount": 20,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "The slide uses a four-column layout to summarize the market, target, product, and pipeline potential.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-dba4-758b-bcbe-08ad83e87d71/3",
  "deckHref": "/decks/019de073-dba4-758b-bcbe-08ad83e87d71",
  "deckJsonHref": "/decks/019de073-dba4-758b-bcbe-08ad83e87d71.json",
  "deckAnchorHref": "/decks/019de073-dba4-758b-bcbe-08ad83e87d71#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.38,
        "w": 0.22,
        "x": 0.75,
        "y": 0.345
      },
      "kind": "chart",
      "text": "Pipeline-in-a-Product potential chart",
      "attrs": null,
      "subkind": "donut",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "067d1ae4-b283-43d8-a5a7-3735602775b0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.38,
        "w": 0.22,
        "x": 0.27,
        "y": 0.345
      },
      "kind": "diagram",
      "text": "KIT receptor signaling pathway diagram",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ced70d9e-9b0a-4a91-a984-4538979b1045",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.38,
        "w": 0.22,
        "x": 0.51,
        "y": 0.345
      },
      "kind": "image",
      "text": "THB001 shield logo",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0fbe9827-900f-4e83-b26c-886e5851d153",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.38,
        "w": 0.22,
        "x": 0.03,
        "y": 0.345
      },
      "kind": "image",
      "text": "Patient skin condition photo",
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "59c9fef3-f622-4c34-8c3d-baab8075a643",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.22,
        "x": 0.51,
        "y": 0.72
      },
      "kind": "paragraph",
      "text": "Highly selective oral small molecule with positive clinical responses in Phase 1a clinical trial, PK and PD profile",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "23e1e1ed-ecb2-4408-8d81-2bb8b0040b61",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.22,
        "x": 0.75,
        "y": 0.72
      },
      "kind": "paragraph",
      "text": "Potential to be an attractive oral treatment option for a range of dermal, airway and GI inflammatory diseases",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "38c494fa-2bc0-48b0-8047-1ff0d27d1d93",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.22,
        "x": 0.03,
        "y": 0.72
      },
      "kind": "paragraph",
      "text": "Millions of patients living with severe allergy and other mast cell-mediated diseases; high residual need despite multiple approved products",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a04a6b4b-438c-4287-86e3-ae612f70773c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.22,
        "x": 0.27,
        "y": 0.72
      },
      "kind": "paragraph",
      "text": "Clinical validation of KIT as potentially transformative target for mast cell-mediated diseases",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d59ce2fb-1da3-4cee-a6b9-dc3c6844cedd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.03,
        "y": 0.04
      },
      "kind": "title",
      "text": "Third Harmonic Bio: clinical-stage company with oral wild-type KIT inhibitor to treat mast cell-mediated diseases",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "df370b56-7605-45a2-add0-492384b885ab",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "1bcfbeba-4e6c-4352-8a9e-128be11ef37e",
      "evidence": "This is an executive summary slide with a brief overview of the company and its product.",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}